FDA 510(k) Clearance for ARROW UltraQuik

Peripheral nerve block (PNB) needles look to help increase overall block success for clinicians.

January 24, 2013
Manufacturing Group

Teleflex Inc. officials announce that the ARROW UltraQuik peripheral nerve block (PNB) needles received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

ARROW UltraQuik peripheral nerve block needles are designed to help increase overall block success for clinicians who use ultrasound-guidance when performing single-injection PNBs. UltraQuik needles maintain many of the same clinician-inspired features of the ARROW StimuQuik ECHO needles, including five grooved rings at the distal tip of the needle to help clinicians identify the needle tip under ultrasound.

"Teleflex is pleased to add the ARROW UltraQuik to our line of peripheral nerve block needles," states Cary Vance, president, Anesthesia and Respiratory Division. "The ARROW UltraQuik, StimuQuik and StimuQuik ECHO needles allow us to now offer products to clinicians performing peripheral nerve blocks, whether they use ultrasound only, nerve stimulation only, or a combined approach.”

 

Related

Covestro up and running

September 6, 2015

Former Bayer MaterialScience now legally and economically independent; Leading materials manufacturer has new identity. Read More